← back to search

Chong Zhong

Guangzhou University of Chinese Medicine · CN
Area of research
Hepatology · Surgery
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Liver Disease Diagnosis and Treatment, and Orthodontics and Dentofacial Orthopedics.
h-index
21
citations
1,487
works
90
NIH funding
primary concept
Medicine
email

Recent publications

CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis
Molecular Cancer 2025cited by 32position: lastdoi
Jianpi Huayu decoction enhances the antitumor effect of doxorubicin via piezo1-mediated autophagy in hepatocellular carcinoma
Phytomedicine 2025cited by 5position: lastdoi
Jianpi-huayu Decotion regulates TREM1/DAP12 pathway to improve the immunosuppressive tumor microenvironment and enhance the anti-hepatocellular carcinoma effect of PD-1 inhibitors
Journal of Ethnopharmacology 2025cited by 3position: lastdoi
Jianpi Huayu decoction exerts antitumor effects in pancreatic cancer via SCD1-mediated lipid metabolism remodeling/ferroptosis axis
Phytomedicine 2025cited by 1position: lastdoi
Corrigendum to “Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway” [J. Ethnopharmacol. 279 (2021) 114340]
Journal of Ethnopharmacology 2025cited by 0position: middledoi
Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitors
International Journal of Surgery 2024cited by 31position: middledoi
Hepatocyte-specific SLC27A4 deletion ameliorates nonalcoholic fatty liver disease in mice via suppression of phosphatidylcholine-mediated PXR activation
Metabolism 2024cited by 10position: middledoi
The lack of PPARα exacerbated the progression of non-alcoholic steatohepatitis in mice with spleen deficiency syndrome by triggering an inflammatory response
Frontiers in Immunology 2024cited by 3position: middledoi
[Effect of HBV DNA load on the safety and prognosis of systematic therapy in advanced hepatocellular carcinoma].
PubMed 2024cited by 1position: middledoi
CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis
Research Square 2024cited by 1position: lastdoi
Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity
Cell Biology and Toxicology 2023cited by 20position: middledoi
Drug-eluting beads versus conventional transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
Medicine 2023cited by 10position: middledoi
Hepatectomy versus transcatheter arterial chemoembolization for resectable BCLC stage A/B hepatocellular carcinoma beyond Milan criteria: A randomized clinical trial
Frontiers in Oncology 2023cited by 9position: lastdoi
Adjuvant therapy with Jianpi Huayu decoction improves overall and recurrence-free survival after hepatectomy for hepatocellular carcinoma: a retrospective propensity score-matching study
Frontiers in Pharmacology 2023cited by 7position: lastdoi
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study
Journal of Clinical Oncology 2022cited by 163position: middledoi
Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
Scientific Reports 2022cited by 49position: lastdoi
Hepatic SIRT6 Modulates Transcriptional Activities of FXR to Alleviate Acetaminophen-induced Hepatotoxicity
Cellular and Molecular Gastroenterology and Hepatology 2022cited by 25position: middledoi
Jianpi Huayu decoction inhibits the epithelial–mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling
Journal of Ethnopharmacology 2022cited by 13position: lastdoi
JPHYD Inhibits miR-21-5p/Smad7-Mediated Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells
Journal of Oncology 2022cited by 11position: lastdoi
Examining the Mechanisms of Huachansu Injection on Liver Cancerthrough Integrated Bioinformatics Analysis
Recent Patents on Anti-Cancer Drug Discovery 2022cited by 8position: middledoi
CircFGGY Inhibits Cell Growth, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma via Regulating the miR-545-3p/Smad7 Axis
Frontiers in Cell and Developmental Biology 2022cited by 7position: lastdoi
The Prognostic Value of Serum Apolipoprotein A-I Level and Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer Liver Metastasis
Journal of Oncology 2022cited by 4position: middledoi
Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma
JAMA Network Open 2021cited by 60position: middledoi
Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway
Journal of Ethnopharmacology 2021cited by 58position: middledoi
AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis
International Journal of General Medicine 2021cited by 58position: middledoi
A new horizon in risk stratification of hepatocellular carcinoma by integrating vessels that encapsulate tumor clusters and microvascular invasion
Hepatology International 2021cited by 40position: middledoi
Response to crizotinib in a patient with <i>MET‐</i>amplified hepatocellular carcinoma
Hepatology Research 2021cited by 5position: lastdoi
Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma
International Journal of General Medicine 2021cited by 3position: lastdoi
A Sensitive Liquid Chromatography-Mass Spectrometry Method for Determination of Toosendanin in Rat Plasma and its Application to Pharmacokinetic Study
Journal of Chromatographic Science 2021cited by 2position: middledoi
Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance
Gut 2020cited by 132position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chongkai Fang · Guangzhou University of Chinese Medicine16 papers (2021–2025)Rui Luo · Guangzhou University of Chinese Medicine11 papers (2022–2025)Kun-Liang Feng · Guangzhou University of Chinese Medicine11 papers (2021–2025)Rong Guo · Tsinghua University8 papers (2012–2022)Ruiwei Yao · Guangzhou University of Chinese Medicine7 papers (2023–2025)Ying Zhang · Guangzhou University of Chinese Medicine7 papers (2022–2025)Hanqian Shi · Guangzhou University of Chinese Medicine6 papers (2023–2025)Wei Wei · Zhujiang Hospital6 papers (2012–2024)Chuangpeng Shen · Guangzhou University of Chinese Medicine6 papers (2020–2025)Jinan Wang · Guangzhou University of Chinese Medicine5 papers (2022–2025)Zhisen Pan · Guangzhou University of Chinese Medicine5 papers (2021–2025)Xinqiu Chen · Guangzhou University of Chinese Medicine5 papers (2024–2025)Ji-Nan Wang · Guangzhou University of Chinese Medicine4 papers (2021–2022)Changhui Liu · Guangzhou University of Chinese Medicine4 papers (2020–2024)Lianghe Lu · Sun Yat-sen University4 papers (2020–2022)Chunfeng Xie · Guangzhou University of Chinese Medicine4 papers (2021–2023)Yihong Ling · Sun Yat-sen University3 papers (2021–2022)Haitao Tu · Guangzhou University of Chinese Medicine3 papers (2021–2025)Xiaoyi Xin · Xinjiang Medical University3 papers (2021–2025)Silin Liu · Guangzhou University of Chinese Medicine3 papers (2022–2025)